Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg

Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg is a medicine authorised by Swissmedic under authorisation number 68692. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 February 2023 and the authorisation is limited until 02 February 2028. ATC code C10BA06 places the medicine in the group Lipid modifying agents.

Dispensing category B
Authorisation number 68692
ATC C10BA06
Synthetic medicines

Authorisation data
Authorisation number	68692
Name	Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg
Full name	Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg, Filmtabletten
Authorisation holder	Sandoz Pharmaceuticals AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	C10BA06
First authorisation	03 February 2023
Authorisation validity	02 February 2028

Strengths
No.	Name	Dispensing category	Authorisation date
1	Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg, Filmtabletten	B	03 February 2023
2	Ezetimib Rosuvastatin Sandoz 10 mg / 10 mg, Filmtabletten	B	03 February 2023
3	Ezetimib Rosuvastatin Sandoz 10 mg / 20 mg, Filmtabletten	B	03 February 2023

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	30	mg	C10BA06	07.12.0.	B
2	90	mg	C10BA06	07.12.0.	B
3	30	mg	C10BA06	07.12.0.	B
4	90	mg	C10BA06	07.12.0.	B
5	30	mg	C10BA06	07.12.0.	B
6	90	mg	C10BA06	07.12.0.	B

Scroll the table sideways

Medicines in the same ATC group

Ezetimib Rosuvastatin Spirig HC 10 mg / 10 mgAuthorisation number 68069 · Spirig HealthCare AG · ATC C10BA06B Ezetimib Rosuvastatin Zentiva 10 mg / 10 mgAuthorisation number 68526 · Helvepharm AG · ATC C10BA06B Ezetimib Rosuvastatin axapharm 10 mg/10 mgAuthorisation number 69004 · axapharm ag · ATC C10BA06B Ezetimib-Rosuvastatin Viatris 10 mg / 10 mgAuthorisation number 67276 · Viatris Pharma GmbH · ATC C10BA06B Ezetimib-Rosuvastatin-Mepha 10 mg / 5 mgAuthorisation number 68437 · Mepha Pharma AG · ATC C10BA06B Zenon 10 mg/10 mgAuthorisation number 68502 · Sanofi-Aventis (Suisse) SA · ATC C10BA06B

Other medicines from this authorisation holder

ACC Sandoz 600Authorisation number 53985 · ATC R05CB01D ASS Cardio Sandoz 100 mgAuthorisation number 69724 · ATC B01AC06B Abacavir Lamivudin SandozAuthorisation number 66687 · ATC J05AR02A Abirateron Sandoz 250 mgAuthorisation number 67818 · ATC L02BX03B AclastaAuthorisation number 57363 · ATC M05BA08B Afqlir 40 mg/mlAuthorisation number 70126 · ATC S01LA05B Afqlir 40 mg/mlAuthorisation number 70127 · ATC S01LA05B Alendronat Sandoz 70Authorisation number 57957 · ATC M05BA04B

Frequently asked questions

Is Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg authorised in Switzerland?

Yes. Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg is authorised by Swissmedic under authorisation number 68692, data as of 01 September 2026. The authorisation is limited until 02 February 2028.

Which dispensing category does Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg have?

Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.